Amiel, Thomas
Srinivasan, Shyam
Turrina, Chiara
Ebel, Florian
Straub, Michael
Schwaminger, Sebastian P.
Funding for this research was provided by:
Edith-Haberland-Wagner Stiftung
Medical University of Graz
Article History
Received: 12 April 2024
Accepted: 11 December 2024
First Online: 24 December 2024
Declarations
:
: Shyam Srinivasan, Chiara Turrina, Florian Ebel, Sebastian P. Schwaminger: founded the company Dymium GmbH. In addition, Shyam Srinivasan and Sebastian Schwaminger hold the patents AU2021229560A1, CA3168407A1, CN115243671A, EP3875075B1, EP3875075A1, KR20220143098A, JP2023516703A, US2023149450A1, and WO2021175660A1 all issued by the Technical University of Munich. Shyam Srinivasan also holds the patents EP4144308A1 and WO2023036817A1 filed by the Dymium GmbH. None of the other authors has any other conflict of interest or financial ties to disclose.
: Animal studies were approved by the local governmental review board for animal studies and performed in accordance with current EU regulations and were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Stone models were anonymized to prevent traceability. Ethical approval was obtained from the Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit of the Land Brandenburg (2347-06-2022-25-G) and Ethics Committee of the Technical University of Munich (2023-227-S-KH).